IRIDEX Corporation

US$0.66As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IRIXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (26.06%)
Div yield —
ROE (73.15%)
Medical Devices
Beta (5Y) 0.63
PE TTM —
TSR TTM (37.39%)
Mkt cap US$11.55M
ROIC (18.50%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.724
10.11%
(70.18%)
Sell 1|11|8|7|9
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.01
0.01
0.01
0.01
(2.74%)
(4.14%)
2.25%
4.57%
Revenue$M
1.026
1.032
1.052
1.057
5.98%
6.83%
6.65%
3.25%
Peers (US$11.55M)
Cap (US$)
PE
10.98M
—
Capital
TTM
5Y
10Y
Leveragex
0.265
(0.237)
(0.176)
EBIT/Intx
0.702
0.293
0.295
Own earn%
90.77
23.11
24.50
Sh yield%
39.86
20.57
24.46
Owners
Insiders/Inst%
6.29
87.54
Short interest%
3.04
SBC / revenue%
3.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
3
Op margin range%
5–11
$1 testx
0.0
Incr. ROIC%
31